Tesamorelin | High Purity Research Peptide UK

Tesamorelin High- Purity Research Peptide

Tesamorelin is a synthetic 44-amino acid analogue of Growth Hormone-Releasing Hormone (GHRH), modified with a trans-3-hexenoyl group at the N-terminus for enhanced stability and prolonged activity compared to natural GHRH.

This research peptide works by binding to GHRH receptors in the anterior pituitary gland, stimulating the pulsatile release of endogenous growth hormone (GH). Increased GH levels subsequently elevate IGF-1 (Insulin-like Growth Factor-1), which plays a key role in regulating metabolism, fat breakdown (lipolysis), and lean tissue preservation.

Primary Research Focus:

•  Visceral Fat Reduction — Tesamorelin has been extensively studied for its potential to selectively target and reduce deep abdominal (visceral) adipose tissue while largely sparing subcutaneous fat.

•  Metabolic Health — Investigations into improvements in lipid profiles, including reduced triglycerides and better overall body composition.

•  Growth Hormone Axis — Exploration of its effects on natural GH secretion patterns, IGF-1 levels, and related physiological processes in controlled research settings.

Product Specifications (for GB-Peptides Tesamorelin 10mg):

•  Peptide purity: Research-grade (typically ≥99% as per standard lab testing)

•  Form: Lyophilized powder in a sterile 10mg vial

•  Intended Use: For laboratory research and in vitro/in vivo studies only

•  Storage: Refrigerate at 2–8°C; reconstitute with bacteriostatic water as per standard peptide protocols

Important Notice:

Tesamorelin 10mg is sold strictly for research and laboratory purposes only. It is not for human consumption, diagnostic use, or therapeutic application. GB-Peptides does not endorse or support any off-label or human use of this compound. Always handle in accordance with your institution’s safety and ethical guidelines.

This peptide is a valuable tool for researchers studying growth hormone dynamics, fat metabolism, lipodystrophy models, and age-related metabolic changes.